Imagine a world where your brain works against your wallet — welcome to Gen Z’s dopamine debt, a phenomenon where the brain’s ...

By shutting down a hyperactive enzyme, scientists got damaged brain cells to regrow their lost “antennae” and restart ...

Alto Neuroscience Announces Acquisition of Novel Dopamine Agonist Combination Product Candidate, Adding Late-Stage Readout in Treatment Resistant Depression Within Current Cash Runway ...

MOUNTAIN VIEW, Calif., June 03, 2025--Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for ...

Opioid Receptor Blockers May Help Restore a Healthy Dopamine Balance Researchers have discovered a potentially safer yet effective treatment for multiple dopamine-related disorders.

Summary: New research identifies a promising strategy for correcting dopamine imbalances in the brain using a drug that blocks kappa opioid receptors (KOR). In mouse models with a rare mutation that ...

By blocking dopamine-1 receptors, ecopipam is expected to reduce the repetitive and compulsive behaviors seen in Tourette syndrome.

Topline data were announced from a phase 3 trial evaluating ecopipam, a dopamine-1 receptor antagonist, in pediatric and adult patients with Tourette syndrome.

Emalex Biosciences’ dopamine blocker led to fewer patients with Tourette syndrome relapsing in a phase 3 trial, setting the stage for the Chicago-based firm to submit the drug candidate for ...

A dopamenu is a personalized list of small, rewarding activities designed to boost focus, motivation and well-being. Here are 5 things to know about building one.